{
    "Trade/Device Name(s)": [
        "SPIFE IFE-3 Pentavalent Kit",
        "SPIFE IFE-6 Pentavalent Kit",
        "SPIFE IFE-9 Pentavalent Kit",
        "SPIFE IFE-15 Pentavalent Kit",
        "SPIFE IFE Pentavalent Antisera Kits"
    ],
    "Submitter Information": "Helena Laboratories",
    "510(k) Number": "K061069",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFF",
        "DFH",
        "DEH"
    ],
    "Summary Letter Date": "July 6, 2006",
    "Summary Letter Received Date": "April 17, 2006",
    "Submission Date": "April 13, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, E Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Immunoglobulin A",
        "Immunoglobulin G",
        "Immunoglobulin M",
        "Immunoglobulin D",
        "Immunoglobulin E",
        "Abnormal immunoglobulins"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SPIFE 2000 system",
        "SPIFE 3000 system"
    ],
    "Method(s)/Technology(ies)": [
        "Protein electrophoresis",
        "Immunofixation"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for SPIFE IFE Pentavalent Antisera Kits for qualitative separation of abnormal immunoglobulins in serum by electrophoresis and immunofixation on SPIFE 2000/3000 systems",
    "Indications for Use Summary": "Intended for qualitative in vitro diagnostic separation of abnormal immunoglobulins in serum using protein electrophoresis and immunofixation on SPIFE 2000/3000 systems; aids in screening abnormal proteins in conjunction with clinical and other findings",
    "fda_folder": "Immunology"
}